Nightingale Health Oyj
HEALTH.HE operates in the healthcare diagnostics industry, providing services and solutions related to medical diagnostics and research.
Business. HEALTH.HE is a healthcare diagnostics company operating within the biotechnology and medical research industry. The firm is headquartered in Finland and is primarily listed on the Nasdaq Helsinki exchange under the ticker HEALTH.HE. Specific details regarding operating segments and geographic revenue mix are not available.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
HEALTH.HE is a healthcare diagnostics company operating within the biotechnology and medical research industry. The firm is headquartered in Finland and is primarily listed on the Nasdaq Helsinki exchange under the ticker HEALTH.HE. Specific details regarding operating segments and geographic revenue mix are not available.
HEALTH.HE has a market price of 0.86 EUR and a market cap of 34,860,253.94 EUR, indicating a relatively small capitalization. The company's price-to-book ratio is 0.53, and its price-to-tangible-book ratio is also 0.53, suggesting that the company's market value is significantly lower than its book value. The enterprise value to EBITDA ratio is 0.147, and the enterprise value to revenue ratio is -0.61, indicating a negative valuation multiple.
In terms of profitability, HEALTH.HE has a return on equity of -0.279 and a return on assets of -0.2478, both of which are negative, indicating that the company is not generating returns for its shareholders or assets. The company's operating income and net income are both negative, at -19,417,000 EUR and -18,462,000 EUR, respectively, showing that the company is currently operating at a loss.
HEALTH.HE's revenue is 4,693,000 EUR, and its gross profit is 3,555,000 EUR. The company's revenue concentration is not specified, but the lack of segment data suggests that the company may not have a diversified revenue stream. The company's capital expenditure is -4,154,000 EUR, indicating that it is investing in its operations.
Looking at the company's growth trajectory, HEALTH.HE's operating cash flow is -10,108,000 EUR, and its free cash flow is -14,322,000 EUR, both of which are negative, indicating that the company is not generating positive cash flow from its operations. The company's liquidity is low, with a current ratio of 8.8, suggesting that it has sufficient current assets to cover its current liabilities.
In terms of risk factors, HEALTH.HE has a low liquidity risk and a low dilution risk. The company has no immediate filing-based liquidity or dilution flags, indicating that it is not currently facing significant financial risks. The company's debt-to-equity ratio is 0.05, indicating that it has a low level of debt relative to its equity.
Recent events related to HEALTH.HE include analyst estimates, with a mean price target of 1.70 EUR and a mean recommendation of 2.00, indicating a neutral stance from analysts. The company has one buy recommendation and no strong-buy or hold recommendations, suggesting that analysts are not overly optimistic about the company's future performance.
- HEALTH.HE is a small-cap healthcare diagnostics company with a market cap of 34,860,253.94 EUR.
- The company is currently operating at a loss, with negative operating and net income.
- HEALTH.HE has a low liquidity risk and a low dilution risk, with no immediate filing-based flags.
- Analysts have a neutral stance on the company, with a mean price target of 1.70 EUR.
- The company's financial metrics, including return on equity and return on assets, are negative, indicating poor performance.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | -0,27 |
| Revenue | —no estimate | —no estimate | 7,6M EUR |
| Operating income | —no estimate | —no estimate | -16,4M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- HEALTH.HE Market data — financials · 2026-05-28
- Nightingale Health Oyj Market data — analyst estimates · 2026-05-28